Outcome of 232 morbidly obese patients treated with laparoscopic adjustable gastric banding between 1995-2003.
Laparoscopic adjustable gastric banding (LAGB) is widely used for the treatment of morbidly obese patients. We prospectively evaluated the effect of LAGB since 1995. Between March 1995 and August 2003, 232 morbidly obese patients underwent LAGB. The pars flaccida technique was used in the majority of the patients. Data were prospectively collected. The median age was 35 years and 93% were female. Initial median body weight was 129 kg with a median BMI of 46. After 5 years of follow-up, median BMI decreased to 36 and the median body weight decreased to 98 kg. Median excess weight loss was 37% after 1 year, 42% after 3 years and 42% after 5 years of follow-up. Late postoperative complications were pouch dilatation (n = 33), port revision (n = 19), erosion (n = 4) and necrosis (n = 1). LAGB is a safe and successful treatment for patients with morbid obesity. Maximal weight reduction is achieved within 12 months and remains stable up to at least 5 years. These results suggest that LAGB could have a positive outcome on morbid obesity-associated morbidity and overall life expectancy.